ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 140 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,182,000 | -69.4% | 377,728 | -60.2% | 0.05% | -66.9% |
| Q2 2022 | $26,699,000 | +56.7% | 950,151 | +157.3% | 0.16% | +103.9% |
| Q1 2022 | $17,041,000 | -45.1% | 369,329 | 0.0% | 0.08% | -33.6% |
| Q4 2021 | $31,046,000 | -10.0% | 369,329 | -28.7% | 0.12% | -17.7% |
| Q3 2021 | $34,500,000 | +34.4% | 517,712 | +7.3% | 0.14% | +27.0% |
| Q2 2021 | $25,672,000 | +31.5% | 482,558 | +7.2% | 0.11% | -8.3% |
| Q1 2021 | $19,526,000 | +67.1% | 450,000 | +100.0% | 0.12% | +70.4% |
| Q4 2020 | $11,687,000 | – | 225,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 2,099,583 | $42,117,635 | 14.06% |
| Mayo Clinic | 187,143 | $3,754,089 | 7.23% |
| Matrix Capital Management Company, LP | 13,959,973 | $280,037,058 | 3.36% |
| 5AM Venture Management, LLC | 490,000 | $9,829,400 | 2.83% |
| Eventide Asset Management | 7,814,039 | $156,749,622 | 2.82% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 961,486 | $19,287,410 | 2.70% |
| Avidity Partners Management LP | 2,100,000 | $42,126,000 | 1.70% |
| First Light Asset Management, LLC | 848,477 | $17,020,449 | 1.62% |
| Sofinnova Investments, Inc. | 1,211,641 | $24,305,518 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 386,525 | $7,753,692 | 1.51% |